UNION therapeutics

UNION therapeutics is a clinical-stage drug development company focused on the identification, development, and commercialization of treatments in immunology and infectious diseases. Our current portfolio consists of pharmaceutical compounds with established modes of action, holding significant potential to address unmet medical needs. UNION therapeutics operates with a scalable and capital-efficient business model built on identifying and developing well-characterized molecules with broad applicability and demonstrated safety profiles in immunology and infectious diseases. Our goal is to maintain a clinical-stage pipeline that shortens time-to-market while generating multiple growth opportunities by expanding the scope of existing molecules, introducing new molecules from our existing platform, and licensing novel molecules.